{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:46:16Z","timestamp":1795023976074,"version":"4.10.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate and compare the clinical features, imaging, overlapping antibodies, and prognosis of pediatric and adult patients with anti-GFAP antibodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study included 59 patients with anti-GFAP antibodies (28 females and 31 males) who were admitted between December 2019 and September 2022.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 59 patients, 18 were children (under 18 years old), and 31 were adults. The overall cohort\u2019s median age at onset was 32 years old, 7 for children, and 42 for adults. There were 23 (41.1%) patients with prodromic infection, 1 (1.7%) patient with a tumor, 29 (53.7%) patients with other non-neurological autoimmune diseases, and 17 (22.8%) patients with hyponatremia. Fourteen (23.7%) patients had multiple neural autoantibodies, with the AQP4 antibody being the most common. Encephalitis (30.5%) was the most common phenotypic syndrome. Common clinical symptoms included fever (59.3%), headache (47.5%), nausea and vomiting (35.6%), limb weakness (35.6%), and disturbance of consciousness (33.9%). Brain MRI lesions were primarily located in the cortex\/subcortex (37.3%), brainstem (27.1%), thalamus (23.7%), and basal ganglia (22.0%). Spinal cord MRI lesions often involved the cervical and thoracic spinal cord. There was no statistically significant difference in the MRI lesion site between children and adults. Out of 58 patients, 47 (81.0%) had a monophasic course, and 4 died. The last follow-up showed that 41\/58 (80.7%) patients had an improved functional outcome (mRS &amp;lt;3), and children were more likely than adults to have no residual disability symptoms (p = 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There was no statistically significant difference in clinical symptoms and imaging findings between children and adult patients with anti-GFAP antibodies; Patients with anti-GFAP antibodies may present with normal MRI findings or delayed MRI abnormalities, and patients with overlapping antibodies were common. Most patients had monophasic courses, and those with overlapping antibodies were more likely to relapse. Children were more likely than adults to have no disability. Finally, we hypothesize that the presence of anti-GFAP antibodies is a non-specific witness of inflammation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1106490","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T13:17:30Z","timestamp":1683033450000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical, imaging features and outcomes of patients with anti-GFAP antibodies: a retrospective study"],"prefix":"10.3389","volume":"14","author":[{"given":"Bingqing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2015.3881","article-title":"Plasma anti-glial fibrillary acidic protein autoantibody levels during the acute and chronic phases of traumatic brain injury: a transforming research and clinical knowledge in traumatic brain injury pilot study","volume":"33","author":"Wang","year":"2016","journal-title":"J Neurotrauma"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-052016\u2013100218","article-title":"Disorders of astrocytes: Alexander disease as a model","volume":"12","author":"Olabarria","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23734","article-title":"Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes","volume":"68","author":"Li","year":"2020","journal-title":"Glia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13531","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study","volume":"25","author":"Long","year":"2018","journal-title":"Eur J Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02802","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature","volume":"9","author":"Shan","year":"2018","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00251","article-title":"Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies","volume":"9","author":"Yang","year":"2018","journal-title":"Front Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/wco.0000000000000676","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy","volume":"32","author":"Kunchok","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017\u2013316583","article-title":"Clinical and immunological characteristics of the spectrum of gfap autoimmunity: a case series of 22 patients","volume":"89","author":"Iorio","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000013087","article-title":"Glial fibrillary acidic protein autoimmunity: a French cohort study","volume":"98","author":"Gravier-Dumonceau","year":"2022","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000200029","article-title":"Area postrema syndrome in autoimmune glial fibrillary acidic protein astrocytopathy: a case series and literature review","volume":"9","author":"Deng","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.02.020","article-title":"Autoimmune gfap astrocytopathy after viral encephalitis: a case report","volume":"21","author":"Li","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.04.016","article-title":"Autoimmune gfap astrocytopathy: prospective evaluation of 90 patients in 1 Year","volume":"321","author":"Dubey","year":"2018","journal-title":"J Neuroimmunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577718","article-title":"Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: a pooled analysis of 324 cases from published data and a single-center retrospective study","volume":"360","author":"Xiao","year":"2021","journal-title":"J Neuroimmunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.04.004","article-title":"Clinical characteristics of autoimmune gfap astrocytopathy","volume":"332","author":"Kimura","year":"2019","journal-title":"J Neuroimmunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8964\u201321","article-title":"Repeated brain magnetic resonance imaging provides clues for the diagnosis of autoimmune glial fibrillary acid protein astrocytopathy","volume":"61","author":"Natori","year":"2022","journal-title":"Intern Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9724\u201322","article-title":"Delayed appearance of brain magnetic resonance imaging abnormalities in a patient with glial fibrillary acidic protein astrocytopathy","volume":"62","author":"Izumi","year":"2022","journal-title":"Intern Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2022.100403","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy with delayed abnormal magnetic resonance imaging findings","volume":"27","author":"Imanaka","year":"2022","journal-title":"eNeurologicalSci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40120\u2013021\u201300302-y","article-title":"Glial fibrillary acidic protein (Gfap) astrocytopathy presenting as mild encephalopathy with reversible splenium lesion","volume":"11","author":"H\u00e9raud","year":"2022","journal-title":"Neurol Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejpn.2020.03.002","article-title":"Mild Encephalitis\/Encephalopathy with reversible splenial lesion syndrome: an unusual presentation of anti-gfap astrocytopathy","volume":"26","author":"Oger","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.761354","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in children: a retrospective analysis of 35 cases","volume":"12","author":"Fang","year":"2021","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302911","article-title":"Relapsing-remitting central nervous system autoimmunity mediated by gfap-specific Cd8 T cells","volume":"192","author":"Sasaki","year":"2014","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14778","article-title":"Cd8(+) T-cell predominance in autoimmune glial fibrillary acidic protein astrocytopathy","volume":"28","author":"Yuan","year":"2021","journal-title":"Eur J Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000001081","article-title":"Autopsy case of meningoencephalomyelitis associated with glial fibrillary acidic protein antibody","volume":"8","author":"Yamakawa","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000479948","article-title":"Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases","volume":"24","author":"Yang","year":"2017","journal-title":"Neuroimmunomodulation"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102350","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy mimics infectious meningitis: two case reports","volume":"45","author":"Yang","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e26448","DOI":"10.1097\/md.0000000000026448","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy mimicking acute disseminated encephalomyelitis: a case report","volume":"100","author":"Li","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.09.029","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy masquerading as tuberculosis of the central nervous system: a case series","volume":"124","author":"Quek","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107272","article-title":"A case of autoimmune glial fibrillary acidic protein astrocytopathy presenting with magnetic resonance imaging mimics of multiple sclerosis","volume":"218","author":"Sakashita","year":"2022","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1106490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T13:17:35Z","timestamp":1683033455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1106490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2023.1106490"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1106490","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"article-number":"1106490"}}